Great Elm Capital Corp. ("GECC") Addresses Investor Questions with Respect to its First Brands Investments

Stock Information for Lineage Cell Therapeutics, Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Lineage Cell Therapeutics, Inc.

Great Elm Capital Corp. Announces Third Quarter 2025 Financial Results
Great Elm Capital Corp. ("GECC") Schedules Third Quarter 2025 Earnings Release and Conference Call
Great Elm Capital Corp. Prices Public Offering of $50 Million of 7.75% Notes Due 2030
Great Elm Capital Corp. Announces Public Offering of Unsecured Notes
Great Elm Group Announces Strategic Investments, New Board Member, and Timing of Fiscal 2025 Earnings Release
Great Elm Capital Corp. ("GECC") Raises $15.0 Million of Equity
Great Elm Capital Corp. Announces Amended and Upsized Revolving Credit Facility
Great Elm Capital Corp. Announces Second Quarter 2025 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.